Startseite
Impressum
Datenschutz
 
Volume 38, 14 September 2007 9/2007
 
  NEW ON THE MARKET
 

A new anti-hypertensive drug: aliskiren (RASILEZ)

 
  THERAPY FROM A CRITICAL VIEWPOINT

Thiazide diuretics: first choice for diabetic patients with hypertension
What is the evidence for hip protectors?

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Testosterone patch INTRINSA for women after surgical castration?
ACE-inhibitors for coronary heart disease even without heart failure?
Strontium ranelate (PROTELOS): prevention of non-vertebral fractures proven?
Janssen-Cilag's comment on paliperidone (INVEGA)

 
  IN BRIEF
 

QTc-prolongation: clobutinol antitussives (e.g. SILOMAT) off market
Call for a register for doctor's fees from the industry

 
  CURRENT ADR NETWORK REPORT
 

Montelukast (SINGULAIR) and depression

 
  SIDE EFFECTS
 

Valproate (e.g. ORFIRIL): pubertas praecox and endocrine effects
Botulinum toxin (e.g. BOTOX): dysphagia, myasthenia and death

 
© arznei-telegramm 9/2007